Literature DB >> 11358949

Enhancement of angiotensinogen expression in angiotensin II-dependent hypertension.

H Kobori1, L M Harrison-Bernard, L G Navar.   

Abstract

Chronic infusion of angiotensin (Ang) II leads to the development of hypertension and enhances intrarenal Ang II content to levels greater than can be explained from the circulating concentrations of the peptide. We previously reported that renal angiotensinogen (Ao) mRNA is enhanced in Ang II-dependent hypertension and may contribute to augmented intrarenal Ang II levels, but the Ao protein levels were not significantly increased. Because a high-salt diet (H/S) has been shown to suppress renal expression of Ao mRNA, we examined the effects of chronic Ang II infusion on kidney and liver Ao mRNA and protein levels in male Sprague-Dawley rats (n=12) maintained on an 8% salt diet. Ang II was administered via osmotic minipumps (40 ng/min) to 1 group (n=6) while the remaining rats were sham-operated. A H/S diet alone did not alter systolic blood pressure in sham animals (109+/-6 mm Hg at day 12); however, Ang II infusions to the H/S rats significantly increased systolic blood pressure (167+/-7 at day 12) and intrarenal Ang II content (459+/-107 fmol/g versus 270+/-42) despite a marked suppression of plasma renin activity (0.9+/-0.2 ng Ang I. mL(-1). h(-1) versus 2.8+/-1.3). Ang II infusions significantly increased kidney Ao mRNA compared with the H/S diet alone by 1.9+/-0.1-fold. Western blot analysis of kidney protein extracts showed that the Ang II-infused rats had increased kidney Ao protein levels compared with the H/S diet alone (1.9+/-0.1-fold). Liver Ao mRNA and protein and plasma Ao protein were also significantly increased by Ang II infusions. These data demonstrate the effects of Ang II infusion to stimulate Ao mRNA and protein. Thus, the augmented intrarenal Ang II in Ang II-dependent hypertension may result, in part, by a positive amplification mechanism to activate renal expression of AO:

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11358949      PMCID: PMC2575649          DOI: 10.1161/01.hyp.37.5.1329

Source DB:  PubMed          Journal:  Hypertension        ISSN: 0194-911X            Impact factor:   10.190


  37 in total

1.  Targeted gene duplication and disruption for analyzing quantitative genetic traits in mice.

Authors:  O Smithies; H S Kim
Journal:  Proc Natl Acad Sci U S A       Date:  1994-04-26       Impact factor: 11.205

2.  Expression of angiotensinogen mRNA and protein in angiotensin II-dependent hypertension.

Authors:  Hiroyuki Kobori; Lisa M Harrison-Bernard; L Gabriel Navar
Journal:  J Am Soc Nephrol       Date:  2001-03       Impact factor: 10.121

3.  Angiotensinogen concentrations and renin clearance : implications for blood pressure regulation.

Authors:  J Bohlender; J Ménard; D Ganten; F C Luft
Journal:  Hypertension       Date:  2000-03       Impact factor: 10.190

4.  Novel mechanism of hypertension revealed by cell-specific targeting of human angiotensinogen in transgenic mice.

Authors:  R L Davisson; Y Ding; D E Stec; J F Catterall; C D Sigmund
Journal:  Physiol Genomics       Date:  1999-07-15       Impact factor: 3.107

5.  Cloning and sequence analysis of cDNA for rat angiotensinogen.

Authors:  H Ohkubo; R Kageyama; M Ujihara; T Hirose; S Inayama; S Nakanishi
Journal:  Proc Natl Acad Sci U S A       Date:  1983-04       Impact factor: 11.205

6.  Augmentation of intrarenal angiotensin II levels by chronic angiotensin II infusion.

Authors:  A M Von Thun; R C Vari; S S el-Dahr; L G Navar
Journal:  Am J Physiol       Date:  1994-01

7.  Angiotensin II stimulates the synthesis of angiotensinogen in hepatocytes by inhibiting adenylylcyclase activity and stabilizing angiotensinogen mRNA.

Authors:  C Klett; R Nobiling; P Gierschik; E Hackenthal
Journal:  J Biol Chem       Date:  1993-11-25       Impact factor: 5.157

8.  Activation of angiotensinogen gene in cardiac myocytes by angiotensin II and mechanical stretch.

Authors:  K Tamura; S Umemura; N Nyui; K Hibi; T Ishigami; M Kihara; Y Toya; M Ishii
Journal:  Am J Physiol       Date:  1998-07

9.  PCR localization of angiotensin II receptor and angiotensinogen mRNAs in rat kidney.

Authors:  Y Terada; K Tomita; H Nonoguchi; F Marumo
Journal:  Kidney Int       Date:  1993-06       Impact factor: 10.612

10.  Rat proximal tubule cell line transformed with origin-defective SV40 DNA: autocrine ANG II feedback.

Authors:  J R Ingelfinger; F Jung; D Diamant; L Haveran; E Lee; A Brem; S S Tang
Journal:  Am J Physiol       Date:  1999-02
View more
  93 in total

Review 1.  Renal renin-angiotensin system.

Authors:  Atsuhiro Ichihara; Hiroyuki Kobori; Akira Nishiyama; L Gabriel Navar
Journal:  Contrib Nephrol       Date:  2004       Impact factor: 1.580

Review 2.  Evidence for a functional intracellular angiotensin system in the proximal tubule of the kidney.

Authors:  Brianne Ellis; Xiao C Li; Elisa Miguel-Qin; Victor Gu; Jia L Zhuo
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2011-12-14       Impact factor: 3.619

3.  Augmented intratubular renin and prorenin expression in the medullary collecting ducts of the kidney as a novel mechanism of angiotensin II-induced hypertension.

Authors:  Jia L Zhuo
Journal:  Am J Physiol Renal Physiol       Date:  2011-10-12

4.  Enhanced urinary angiotensinogen excretion in Cyp1a1-Ren2 transgenic rats with inducible ANG II-dependent malignant hypertension.

Authors:  Carlo J Milani; Hiroyuki Kobori; John J Mullins; Kenneth D Mitchell
Journal:  Am J Med Sci       Date:  2010-11       Impact factor: 2.378

5.  Divergent localization of angiotensinogen mRNA and protein in proximal tubule segments of normal rat kidney.

Authors:  Masumi Kamiyama; Kristina M Farragut; Michelle K Garner; L Gabriel Navar; Hiroyuki Kobori
Journal:  J Hypertens       Date:  2012-12       Impact factor: 4.844

Review 6.  Intrarenal angiotensin II and hypertension.

Authors:  L Gabriel Navar; Hiroyuki Kobori; Minolfa Prieto-Carrasquero
Journal:  Curr Hypertens Rep       Date:  2003-04       Impact factor: 5.369

7.  Angiotensin-converting enzyme-derived angiotensin II formation during angiotensin II-induced hypertension.

Authors:  Romer A Gonzalez-Villalobos; Ryousuke Satou; Dale M Seth; Laura C Semprun-Prieto; Akemi Katsurada; Hiroyuki Kobori; L Gabriel Navar
Journal:  Hypertension       Date:  2008-12-15       Impact factor: 10.190

8.  Urinary angiotensinogen as a novel biomarker of the intrarenal renin-angiotensin system status in hypertensive patients.

Authors:  Hiroyuki Kobori; A Brent Alper; Rajesh Shenava; Akemi Katsurada; Toshie Saito; Naro Ohashi; Maki Urushihara; Kayoko Miyata; Ryousuke Satou; L Lee Hamm; L Gabriel Navar
Journal:  Hypertension       Date:  2008-12-15       Impact factor: 10.190

9.  Urinary angiotensinogen as a potential biomarker of severity of chronic kidney diseases.

Authors:  Hiroyuki Kobori; Naro Ohashi; Akemi Katsurada; Kayoko Miyata; Ryousuke Satou; Toshie Saito; Tatsuo Yamamoto
Journal:  J Am Soc Hypertens       Date:  2008 Sep-Oct

10.  Purinergic receptors contribute to early mesangial cell transformation and renal vessel hypertrophy during angiotensin II-induced hypertension.

Authors:  Miguel L Graciano; Akira Nishiyama; Keith Jackson; Dale M Seth; Rudy M Ortiz; Minolfa C Prieto-Carrasquero; Hiroyuki Kobori; L Gabriel Navar
Journal:  Am J Physiol Renal Physiol       Date:  2007-11-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.